104 related articles for article (PubMed ID: 6626926)
1. Long term results of 66 femoral-to-femoral by-pass grafts: a 9-year follow-up.
Mosley JG; Marston A
Br J Surg; 1983 Oct; 70(10):631-4. PubMed ID: 6626926
[TBL] [Abstract][Full Text] [Related]
2. A 5 year follow-up of Dacron femoropopliteal bypass grafts.
Mosley JG; Marston A
Br J Surg; 1986 Jan; 73(1):24-7. PubMed ID: 2936417
[TBL] [Abstract][Full Text] [Related]
3. Treatment of unilateral iliac artery disease by femorofemoral bypass grafting.
Sheiner NM; Ashby D; Zeltzer J
Can J Surg; 1979 Sep; 22(5):474-6. PubMed ID: 159115
[TBL] [Abstract][Full Text] [Related]
4. Femoro-femoral arterial bypass is an effective and durable treatment for symptomatic unilateral iliac artery occlusion.
Pai M; Handa A; Hands L; Collin J
Ann R Coll Surg Engl; 2003 Mar; 85(2):88-90. PubMed ID: 12648336
[TBL] [Abstract][Full Text] [Related]
5. [Factors determining late patency of aortobifemoral bypass graft].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
[TBL] [Abstract][Full Text] [Related]
6. Complications with the mandril-grown (Sparks) dacron arterial graft.
Hallin RW
Am Surg; 1975 Sep; 41(9):550-4. PubMed ID: 126653
[TBL] [Abstract][Full Text] [Related]
7. A comparative evaluation of femorofemoral crossover bypass and iliofemoral bypass for unilateral iliac artery occlusive disease.
Nazzal MM; Hoballah JJ; Jacobovicz C; Mohan CR; Martinasevic M; Ryan SM; Sharp WJ; Kresowik TF; Corson JD
Angiology; 1998 Apr; 49(4):259-65. PubMed ID: 9555928
[TBL] [Abstract][Full Text] [Related]
8. Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome.
Criado E; Burnham SJ; Tinsley EA; Johnson G; Keagy BA
J Vasc Surg; 1993 Sep; 18(3):495-504; discussion 504-5. PubMed ID: 8377244
[TBL] [Abstract][Full Text] [Related]
9. Randomized comparison of ePTFE/nitinol self-expanding stent graft vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Hohman S; Pearl G; Theune B
J Vasc Surg; 2009 Jan; 49(1):109-15, 116.e1-9; discussion 116. PubMed ID: 19028055
[TBL] [Abstract][Full Text] [Related]
10. [High recurrence rate following axillofemoral bypass: is continued use still justified?].
Hepp W; Pallua N
Zentralbl Chir; 1985; 110(18):1138-46. PubMed ID: 4082804
[TBL] [Abstract][Full Text] [Related]
11. [Dacron and polytetrafluoroethylene aorto-bifemoral grafts].
Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanović PL; Velimirović LB; Marković DM; Pejkić SL; Pavlović G
Srp Arh Celok Lek; 1997; 125(3-4):75-83. PubMed ID: 9221522
[TBL] [Abstract][Full Text] [Related]
12. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease.
Ricco JB; Probst H;
J Vasc Surg; 2008 Jan; 47(1):45-53; discussion 53-4. PubMed ID: 17997269
[TBL] [Abstract][Full Text] [Related]
13. Surgical treatment of aorto-iliac artery disease.
Chang JB
Angiology; 1981 Feb; 32(2):73-105. PubMed ID: 6452076
[TBL] [Abstract][Full Text] [Related]
14. Fallibility of postoperative Doppler ankle pressures in determining the adequacy of proximal arterial revascularization.
Kozloff L; Collins GJ; Rich NM; McDonald PT; Collins JT; Clagett GP
Am J Surg; 1980 Mar; 139(3):326-9. PubMed ID: 6444784
[TBL] [Abstract][Full Text] [Related]
15. Stent grafts for iliofemoral occlusive disease.
Nevelsteen A; Lacroix H; Stockx L; Wilms G
Cardiovasc Surg; 1997 Aug; 5(4):393-7. PubMed ID: 9350794
[TBL] [Abstract][Full Text] [Related]
16. [Bifurcated prosthesis in infrarenal aortic position in stenosing lesions. Functional results].
Illuminati G; Bertagni A; Caliò FG; Antonaci A; Vietri F
Minerva Chir; 1997 Jun; 52(6):789-94. PubMed ID: 9324663
[TBL] [Abstract][Full Text] [Related]
17. Four-year randomized prospective comparison of percutaneous ePTFE/nitinol self-expanding stent graft versus prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease.
McQuade K; Gable D; Pearl G; Theune B; Black S
J Vasc Surg; 2010 Sep; 52(3):584-90; discussion 590-1, 591.e1-591.e7. PubMed ID: 20598480
[TBL] [Abstract][Full Text] [Related]
18. [Value of profunda revascularization in aorto-femoral 2-level occlusion].
Hohlbach G; Nielsen H; Muhl E; Kummer D; Schildberg FW
Vasa Suppl; 1989; 27():318-9. PubMed ID: 2623526
[No Abstract] [Full Text] [Related]
19. Femorofemoral bypass as an alternative to a direct aortic approach in daily practice: appraisal of its current indications and midterm results.
Rinckenbach S; Guelle N; Lillaz J; Al Sayed M; Ritucci V; Camelot G
Ann Vasc Surg; 2012 Apr; 26(3):359-64. PubMed ID: 22050878
[TBL] [Abstract][Full Text] [Related]
20. Femorofemoral grafting: indications and late results.
Mannick JA; Maini BS
Am J Surg; 1978 Aug; 136(2):190-2. PubMed ID: 686260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
